ArticleBMC ophthalmology2025
Age and initial spherical equivalent influence the axial length elongation in children aged 9-17 years undergoing orthokeratology therapy.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Real-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study.Turkish journal of ophthalmology · 2026Observational
- Axial length changes and baseline predictors over five years in children treated with orthokeratology lenses: a retrospective cohort study.Frontiers in bioengineering and biotechnology · 2026Article
- Baseline ocular biometrics in children with orthokeratology-induced axial length reduction or elongation.BMC ophthalmology · 2025Article
- Orthokeratology for myopia control: a three-year longitudinal study on axial length modulation influenced by baseline age and spherical equivalent.BMC ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundOrthokeratology (Ortho-K) lenses are increasingly used in children to manage myopia by reshaping the cornea and potentially influencing axial length changes. This study investigated factors affecting axial length changes in children aged 9-17 years wearing Ortho-K lenses, focusing on age, initial spherical value, and other parameters.
methodsThis retrospective analysis included 84 children (49 males, 35 females, aged 9-17 years) who wore Ortho-K lenses at the Tenth Affiliated Hospital of Southern Medical University between January 2018 and December 2019, with a minimum follow-up of 12 months. Subjects met specific inclusion criteria, including myopia ≤ 6.00 DS and astigmatism ≤ 1.75 DC. Comprehensive ocular examinations were conducted, and axial length changes were measured using an IOL-Master500.
resultsUnivariate analysis revealed significant factors influencing axial length changes, including age (F = -5.476, P < 0.001) and initial equivalent spherical value (F = 8.314, P = 0.004). Mixed-effects model analysis confirmed that the duration of lens wear (mean: 18.3 ± 5.4 months), age, initial spherical lens value, and initial axial length significantly impacted axial length (P < 0.05). The mean axial length elongation was 0.18 ± 0.09 mm/year overall, with the low-elongation group showing 0.10 ± 0.05 mm/year and the high-elongation group showing 0.27 ± 0.06 mm/year. Children with lower initial spherical values and older individuals demonstrated less axial elongation.
conclusionAge and initial equivalent spherical value are critical factors influencing axial length changes in children aged 9-17 years who use Ortho-K lenses. Understanding these factors can enhance the effectiveness of Ortho-K treatment in managing myopia progression. Further studies are needed to optimize lens design and treatment protocols for personalized myopia control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.